Ypsomed announced that it launched YpsoLoop, its first autoinjector platform designed for circularity. The Swiss drug delivery device maker says the two new 1 mL and 2.25 mL platforms enable material recovery. Their design enables automated disassembly and efficient recycling while offering the convenience of a pre-filled, two-step autoinjector. Ypsomed said the YpsoLoop platform integrates […]
Business/Financial News
Insulet adds JPMorgan veteran to its board of directors
Insulet (Nasdaq:PODD) announced today that it appointed Robert “Robbie” L. Huffines to its board of directors. Huffines, a former global chair of investment banking at JPMorgan Chase & Co., joins the automated insulin delivery technology maker’s board effective Oct. 31, 2025. He joins as an independent director and a member of the Insulet Audit Committee. […]
Abbott makes Lingo OTC CGM available for sale at Walmart
Abbott (NYSE:ABT) today shared that it made its Lingo biowearable device available for purchase at Walmart stores. This marks the first availability for the over-the-counter continuous glucose monitor (CGM) at a brick-and-morter retailer. It brings the Lingo device to more than 3,500 Walmart Supercenter locations (in their health and wellness sections) in the U.S. and […]
Dexcom is facing a class action suit related to G7 CGM
A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of California. The lawsuit, led by plaintiff Kelly Grisoli on behalf of all others similarly situated, demands a jury trial for claims that Dexcom’s representations for its latest-generation G7 continuous glucose monitor (CGM) were false, misleading, […]
Baxter faces investor lawsuit over infusion pumps
Investors have filed a lawsuit claiming Baxter (NYSE:BAX) violated federal securities laws as a result of issues with certain infusion pumps. Bloomberg Law first reported the filing of the lawsuit in Illinois. The class action suit seeks a trial by jury as investors hope to recover damages related to the rollout of its Novum IQ […]
Civica to launch affordable long-acting insulin in pre-filled pens in 2026
Civica announced today that it plans to launch an affordable long-acting insulin in pre-filled pens starting in January 2026. The company plans to launch insulin glargine-yfgn in pre-filled pens at the lowest list price in the current long-acting insulin market. It intends to make the offering available in the U.S. beginning on Jan. 1, 2026. […]
Abbott CEO expects continued growth in Diabetes Care with Libre 3, dual sensor
Abbott (NYSE:ABT) continues to get a boost in its Medical Devices business from its Diabetes Care unit’s portfolio of continuous glucose monitors (CGMs). In the company’s third-quarter earnings report released today, Abbott — one of the largest medtech companies in the world — fell shy of Wall Street’s sales expectations, but still reported more than 15% […]
Tandem says Abbott FreeStyle Libre 3 integration is ‘coming soon’
On social media, Tandem Diabetes Care (Nasdaq:TNDM) said the launch of a new integration for its insulin pump system is near. “It’s almost here! The t:slim X2 insulin pump integration with the FreeStyle Libre 3 Plus sensor, the world’s smallest continuous glucose monitor, is coming soon,” Tandem wrote on LinkedIn. Tandem announced that it was […]
Ypsomed to open first U.S. manufacturing plant in North Carolina
Ypsomed (SIX:YPSN) announced today that it plans to establish its first manufacturing facility in the U.S. The Swiss drug delivery device maker selected Holly Springs, North Carolina for the location. It plans to invest approximately $249.5 million (CHF 200 million) in the first phase of the plant. It expects the Holy Springs site to supply […]
GE HealthCare unveils new anesthesia delivery system
GE HealthCare (NYSE:GEHC) has unveiled Carestation 850, its next-generation anesthesia delivery system. The FDA 510(k)-pending system aims to help care teams adapt to evolving clinical and operational needs. It could potentially advance anesthesia care through tools, customizable applications and a sleek, space-conscious footprint. Chicago-based GE HealthCare’s FDA submission follows recent CE mark in Europe and […]
